Elevance Health, Inc. (ELV)
(Delayed Data from NYSE)
$274.66 USD
-8.42 (-2.97%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $274.50 -0.16 (-0.06%) 7:58 PM ET
5-Strong Sell of 5 5
A Value F Growth F Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Elevance Health, Inc. has a market cap of $63.74B, which represents its share price of $283.08 multiplied by its outstanding shares number of 225.18M. As a large-cap company, ELV's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ELV 274.66 -8.42(-2.97%)
Will ELV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ELV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELV
Cigna to Report Q2 Earnings: Can Evernorth Offset Healthcare Weakness?
Can Humana Beat Q2 Earnings Estimates on Insurance Unit Strength?
ELV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can Optum Support UnitedHealth's Profit Amid Industry Headwinds?
Medical Expenses Erode Centene's Bottom Line in Rare Q2 Earnings Miss
Company News for Jul 18, 2025
Other News for ELV
Thermo Fisher Scientific Inc Sees Significant Reduction in Eaton Vance Worldwide Health ...
UnitedHealth sets 2025 outlook below consensus amid rising medical costs
UnitedHealth stumbles on weak profit outlook, drags peers lower
UnitedHealth stumbles as annual profit outlook disappoints
UnitedHealth Stock Is A Strong Buy Amid Unfavorable Medical Trends (Upgrade)